NOT-NR-18-003: Notice of NINR's Participation in PA-18-271 Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R21 Clinical Trial Optional)

Notice of NINR's Participation in PA-18-271 Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R21 Clinical Trial Optional)

Notice Number: NOT-NR-18-003

Key Dates
Release Date: March 19, 2018

Related Announcements
PA-18-271

Issued by
National Institute of Nursing Research (NINR)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute of Nursing Research (NINR) is participating in PA-18-271 Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R21 Clinical Trial Optional)

The following changes have been made to reflect NINR's participation in this FOA:

Part 1. Overview Information

Components of Participating Organizations

National Institute of Mental Health (NIMH)

National Institute of Nursing Research (NINR)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.242, 93.361

Part 2. Section VII. Agency Contacts

The following contact has been added:

Scientific/Research Contact(s)

Rebecca Henry, PhD, RN
National Institute of Nursing Research (NINR)
Telephone: 301-594-5976
Email: rebecca.henry@nih.gov

Financial/Grants Management Contact(s)

Kelli Oster
National Institute of Nursing Research (NINR)
Telephone: 301-594-2177
Email: osterk@mail.nih.gov

Inquiries

Please direct all inquiries to:

Rebecca Henry, PhD, RN
National Institute of Nursing Research (NINR)
Telephone: 301-594-5976
Email: rebecca.henry@nih.gov